ReviewPharmaceuticals (Basel, Switzerland)2024

Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment.

Xu Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.